Camille S Mailhac

Title: Camille S Mailhac: Innovator in Single-Domain Antibodies

Introduction

Camille S Mailhac is a notable inventor based in Marseille, France. He has made significant contributions to the field of biotechnology, particularly in the development of single-domain antibodies. His innovative work has led to the creation of a patent that showcases his expertise and dedication to advancing scientific knowledge.

Latest Patents

Camille S Mailhac holds a patent for a single-domain antibody binding to the G protein alpha. This invention relates to a single-domain antibody (sdAb) that binds to the G protein alpha, comprising an amino acid sequence consisting of three CDR regions (CDR1 to CDR3) and four hinge regions (FR1 to FR4). The formula for this invention is represented as FR1-CDR1-FR2-CDR2-FR3-CDR3-FR4 (I), and it advantageously has a dissociation constant (Kd), measured in FRET, of less than 100 nM. This patent highlights his innovative approach to antibody design and its potential applications in therapeutic settings.

Career Highlights

Throughout his career, Camille S Mailhac has worked with prominent organizations, including Cisco Bioassays and the Centre National de la Recherche Scientifique. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Thomas Fabien Michel Roux and Mélanie Da Silva. Their collaborative efforts have further enriched the research environment and fostered innovation in the field of biotechnology.

Conclusion

Camille S Mailhac's contributions to the field of single-domain antibodies exemplify his commitment to scientific advancement. His patent and collaborations reflect his innovative spirit and dedication to improving biotechnological applications.